Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15514249 | 1.00 | SLC15A1 (0.57) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL29819498 | 0.89 | ALDH1A1 (0.50) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL8716286 | 0.88 | ALDH1A1 (0.49) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL29772314 | 0.87 | ALDH1A1 (0.55) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL8882746 | 0.86 | ALDH1A1 (0.47) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL542444 | 0.85 | SLC15A1 (0.61) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL354949 | 0.85 | SLC15A1 (0.61) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2137609 | 0.85 | SLC15A1 (0.61) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL2135391 | 0.83 | SLC15A1 (0.59) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL2137602 | 0.83 | SLC15A1 (0.59) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114144159-B | Nanoparticles comprising dead sea extracts and uses thereof | AHAVA-死海实验室有限公司 | 2024-10-01 | — | — | CN | claimed |
| US-20220183938-A1 | NANOPARTICLES COMPRISING DEAD SEA EXTRACT AND USES THEREOF | AHAVA - DEAD SEA LABORATORIES LTD. (IL) | 2022-06-16 | — | — | US | claimed |
| CN-114144159-A | Nanoparticles comprising dead sea extract and uses thereof | AHAVA-死海实验室有限公司 | 2022-03-04 | — | — | CN | claimed |
| EP-3952826-A1 | NANOPARTICLES COMPRISING DEAD SEA EXTRACT AND USES THEREOF | AHAVA - DEAD SEA LABORATORIES LTD. (IL) | 2022-02-16 | — | — | EP | claimed |
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | CLEARSIDE BIOMEDICAL, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20250345206-A1 | APPARATUS AND METHODS FOR OCULAR INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| US-12350261-B2 | Methods and devices for the treatment of ocular diseases in human subjects | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-07-08 | — | — | US | disclosed |
| US-20250186253-A1 | DEVICES AND METHODS FOR ADJUSTING THE INSERTION DEPTH OF A NEEDLE FOR MEDICAMENT DELIVERY | CLEARSIDE BIOMEDICAL, INC. (US) | 2025-06-12 | — | — | US | disclosed |
| EP-4566672-A2 | METHODS FOR THE TREATMENT OF OCULAR DISEASE IN HUMAN SUBJECTS | Clearside Biomedical Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| EP-3554435-B1 | SYSTEMS FOR DELIVERING DRUGS TO RETINAL TISSUE | CLEARSIDE BIOMEDICAL INC (US) | 2025-06-04 | — | — | EP | disclosed |
| US-20250152413-A1 | SYSTEMS, DEVICES, AND METHODS FOR NEEDLE-LESS OCULAR INJECTIONS | CLEARSIDE BIOMEDICAL INC (US) | 2025-05-15 | — | — | US | disclosed |
| EP-3721872-B1 | METHODS FOR THE TREATMENT OF OCULAR DISEASE IN HUMAN SUBJECTS | CLEARSIDE BIOMEDICAL INC (US) | 2025-01-22 | — | — | EP | disclosed |
| EP-2887982-B1 | APPARATUS FOR DRUG DELIVERY USING MICRONEEDLES | CLEARSIDE BIOMEDICAL INC (US) | 2022-11-23 | — | — | EP | disclosed |
| US-11504431-B2 | Formulations for the suprachoroidal space of an eye and methods | EMORY UNIVERSITY (US) | 2022-11-22 | — | — | US | disclosed |
| US-20220280341-A1 | APPARATUS AND METHODS FOR DRUG DELIVERY USING MICRONEEDLES | CLEARSIDE ROYALTY LLC | 2022-09-08 | — | — | US | disclosed |
| US-20220280386-A1 | METHODS AND APPARATUS FOR EXTRACTING FLUID FROM CONTAINER | CLEARSIDE BIOMEDICAL, INC. | 2022-09-08 | — | — | US | disclosed |
| US-20220183938-A1 | NANOPARTICLES COMPRISING DEAD SEA EXTRACT AND USES THEREOF | AHAVA - DEAD SEA LABORATORIES LTD. (IL) | 2022-06-16 | — | — | US | disclosed |
| WO-2022076938-A1 | APPARATUS AND METHODS OF RETINAL INJECTION | CLEARSIDE BIOMEDICAL, INC. (US) | 2022-04-14 | — | — | WO | disclosed |
| CN-114144159-A | Nanoparticles comprising dead sea extract and uses thereof | AHAVA-死海实验室有限公司 | 2022-03-04 | — | — | CN | disclosed |
| EP-3952826-A1 | NANOPARTICLES COMPRISING DEAD SEA EXTRACT AND USES THEREOF | AHAVA - DEAD SEA LABORATORIES LTD. (IL) | 2022-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | PROKR2, SLC10A2, GLP1R | SLC15A1 315/4885ALDH1A1 4190/4885SLC1A3 290/4885 |
| US-20220183938-A1 | NANOPARTICLES COMPRISING DEAD SEA EXTRACT AND USES THEREOF | CUTA, DSG1, CD63 | SLC15A1 3114/4885ALDH1A1 3761/4885SLC1A3 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.